MENU
SRPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Sarepta Therapeutics (SRPT) Ownership - Who owns Sarepta Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
1314
Web
https://www.sarepta.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.01B
P/E Ratio
81.66
Total Cash
1.2B
Projected Growth
N/A
Total Debt
1.4B
Revenue
1.64B
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
12.55
Total Debt/Equity
0.72
Revenue/Share
16.30 USD as % of share price
Fundamentals
SRPT
Capitalization
12B
P/E Ratio
81.66
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
1.2B
Total Cash/Share
12.55
Total Debt
1.4B
Total Debt/Equity
0.72
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
16.30%
Revenue
1.64B
ROE
N/A
Book Value
1.22B
P/B Ratio
9.84
Cash Flow
N/A
Earnings
1.56
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
3.84
Current Revenue Per Employee
355534.25
Dividends Per Share - Security
N/A
EBITDA
187M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.37
Revenue To Assets
3.63
Shares Held By Institutions
28.6B
Shares Outstanding - Current
95.5M
Total Liabilities
2.38B
Total Volume MTD
N/A
Value
-1
Gain YTD
30.416
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of treatments for life-threatening illnesses and viruses
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
1314
Web
https://www.sarepta.com